Mizuho Medy Co.,Ltd. (TYO:4595)
Japan · Delayed Price · Currency is JPY 1,863.00
+39.00 (2.14%)
Mar 5, 2026, 3:30 PM JST
Mizuho Medy Revenue
In the year 2025, Mizuho Medy had annual revenue of 11.26B JPY, down -1.48%. Mizuho Medy had revenue of 5.03B in the quarter ending December 31, 2025, with 46.34% growth.
Revenue
11.26B
Revenue Growth
-1.48%
P/S Ratio
3.15
Revenue / Employee
60.21M
Employees
187
Market Cap
35.49B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 11.26B | -169.00M | -1.48% |
| Dec 31, 2024 | 11.43B | 440.00M | 4.00% |
| Dec 31, 2023 | 10.99B | -6.59B | -37.50% |
| Dec 31, 2022 | 17.58B | 4.44B | 33.83% |
| Dec 31, 2021 | 13.14B | 8.93B | 212.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KYORIN Pharmaceutical | 133.26B |
| Zeria Pharmaceutical | 86.61B |
| ASKA Pharmaceutical Holdings | 68.70B |
| Pharma Foods International | 66.38B |
| Fuso Pharmaceutical Industries,Ltd. | 62.17B |
| Fuji Pharma | 54.57B |
| Daito Pharmaceutical | 51.20B |
| Koa Shoji Holdings | 23.66B |